Lv5
1146 积分 2024-04-01 加入
Molecular and immune correlates of response to first-line de-escalated chemotherapy plus penpulimab and anlotinib in advanced cervical cancer
3小时前
已完结
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
5天前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
14天前
已完结
The Role of Radiotherapy for Metastatic Cervical Cancer: A Real-World Study
15天前
已完结
Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience
15天前
已完结
Using machine learning to predict remission after surgery for pituitary adenoma: a systematic review and meta-analysis
25天前
已完结
Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: single-center experience
25天前
已关闭
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
1个月前
已完结
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma
1个月前
已完结
Prognostic impact and risk factors of level IV/V lymph nodes metastasis in laryngeal squamous cell carcinoma
2个月前
已完结
皖公网安备34019202002308
